Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dario Health Corp (NQ: DRIO )

4.055 +0.105 (+2.66%)
Streaming Delayed Price Updated: 9:41 AM EDT, Mar 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 792
Open 3.990
Bid (Size) 4.020 (1)
Ask (Size) 4.090 (2)
Prev. Close 3.950
Today's Range 3.990 - 4.055
52wk Range 3.530 - 7.692
Shares Outstanding 25,871,889
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs New Digital Therapeutics Contract with Top-10 PBM
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners with Amwell to Offer Valuable Access to Cardiometabolic Digital Therapeutic Solution
Via Investor Brand Network

Performance

YTD
-6.78%
-6.78%
1 Month
-9.49%
-9.49%
3 Month
+14.87%
+14.87%
6 Month
-11.07%
-11.07%
1 Year
-35.43%
-35.43%

More News

Read More
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Study Results Published, Shows Potential for Digital Therapeutics in Pain Management
Via Investor Brand Network
DarioHealth's Return On Capital Employed Insights
Via Benzinga
Earnings Preview: DarioHealth
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q4 and FY 2022 Results
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Date for Execs to Host Q4 2022 Results Call
Via Investor Brand Network
What Do Sanofi And Dexcom See In DarioHealth That The Market Is Missing?
Via News Direct
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Clinical Outcomes in Two New Studies at Diabetes Conference
Via Investor Brand Network
DarioHealth Corp. (NASDAQ: DRIO) Prominently Positioned for Digital Therapeutics Consolidation
Via TheNewswire.com
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) DarioHealth to Participate in Upcoming Cowen Health Care Conference
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Board Appointment of Health Care Industry Veteran
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expanding Platform to Integrate Market-Leading CGM Data
Via Investor Brand Network
CVS Deal To Buy Oak Street At $39 Per Share Brings Arbitrage Opportunity, Says StoryTrading's Rabizadeh
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Preliminary 2022 Operating Results, Eyes Continued Growth of B2B Revenue
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Names New Senior VP
Via Investor Brand Network
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on New Research in Published Journal Article
Via Investor Brand Network
10 Stocks Under $10 for 2023
Via InvestorPlace
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Validates Position as Leading Provider of Integrated Solutions in Employer and Payer Markets
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Delivering, Well-Positioned in ‘High-Demand’ Market
Via Investor Brand Network
DarioHealth Corp. (NASDAQ: DRIO) Prominently Positioned for Digital Therapeutics Consolidation
Via News Direct
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Move Device Reduces Back Pain, Study Shows
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expands Accounts Utilizing Multi-Chronic Solution
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announce Participation in Upcoming Conferences
Via Investor Brand Network
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.